HighLight Capital
Funding rounds backed by HighLight Capital.
- Funding disclosed in full
- $154M
- Median round
- $77M
- Rounds in calculation
- 2
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Aureka Biotechnologies Builds biological foundation models and closed-loop infrastructure for drug discovery | $100MSeries B | BiotechUnited States | |||
| Vivatides Therapeutics Develops extrahepatic RNA-targeting therapeutics | $54MSeries A | BiotechChina |